Impact of English Proficiency on Case Reporting And Evidence Dissemination In Vascular And Endovascular Medicine

Abstract

English has become the dominant language of scientific communication, particularly in high-impact medical and surgical journals. Vascular and endovascular medicine is a rapidly evolving field where timely case reporting, clinical trial publication, and guideline dissemination are crucial for optimizing patient outcomes. However, variability in English proficiency among clinicians and researchers can significantly shape what evidence is produced, how it is reported, and who can access and apply it. This paper explores the impact of English proficiency on case reporting and evidence dissemination in vascular and endovascular medicine, with a focus on mechanisms of linguistic bias, barriers faced by non–English-speaking or English-as-a-second-language (ESL) clinicians, and the downstream consequences for global vascular care. It examines how limited English proficiency may influence the quality and frequency of case reports, restrict participation in multicenter trials and registries, and contribute to citation and publication biases that privilege English-speaking regions and institutions. The paper further discusses the implications for innovation diffusion, guideline development, and equity in access to best practices, especially in low- and middle-income countries where vascular disease burden is rising. Finally, it proposes a set of pragmatic strategies—including capacity-building in scientific English, editorial and peer-review support, multilingual knowledge products, and ethical use of language technologies—to reduce language-related barriers and promote more inclusive, representative evidence in vascular and endovascular medicine.